Non-invasive assessment of liver inflammation in metabolic dysfunction-associated steatohepatitis (MASH) using MRI cytometry

被引:0
|
作者
Jiang, Xiaoyu [1 ]
Izzy, Manhal [1 ]
Washington, Kay [1 ]
Gore, John [1 ]
Xu, Junzhong [1 ]
机构
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-293
引用
收藏
页码:S595 / S595
页数:1
相关论文
共 50 条
  • [41] Exploring non-invasive diagnostics and non-imaging approaches for pediatric metabolic dysfunction-associated steatotic liver disease
    Yodoshi, Toshifumi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (47)
  • [42] FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis
    Yin, Jing-Ya
    Yang, Tian-Yuan
    Yang, Bing-Qing
    Hou, Chen-Xue
    Li, Jun-Nan
    Li, Yue
    Wang, Qi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (18) : 2440 - 2453
  • [43] 15-year liver outcomes after metabolic surgery in patients with compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)
    Aminian, Ali
    ALJabri, Abdullah
    Wang, Sarah
    Bena, James
    Allende, Daniela
    Rosen, Hana
    Wilson, Rickesha
    Milinovich, Alex
    Loomba, Rohit
    Sanyal, Arun J.
    Alkhouri, Naim
    Wakim-Fleming, Jamile
    Dasarathy, Srinivasan
    McCullough, Arthur
    Nissen, Steven
    JOURNAL OF HEPATOLOGY, 2024, 80 : S76 - S77
  • [44] Thyroid hormone receptor-b analogues for the treatment of metabolic dysfunction-associated steatohepatitis (MASH)
    Ratziu, Vlad
    Scanlan, Thomas S.
    Bruinstroop, Eveline
    JOURNAL OF HEPATOLOGY, 2025, 82 (02) : 375 - 387
  • [45] UNVEILING THE HIDDEN CONNECTION: EXPLORING THE INTERPLAY BETWEEN PERICARDITIS AND METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH)
    Ramirez, Lisnaldy
    Garzon-Siatoya, Wendy
    Aloum, Khalid
    Forlemu, Arnold Nongmoh
    Bandaru, Praneeth
    Ciobanu, Camelia
    Wakil, Ali
    Forlemu, Raissa Nana Sede Mbakop
    Krishna, Vura Naga Venkata Rama
    Sharma, Neha
    HEPATOLOGY, 2024, 80 : S472 - S472
  • [46] ECONOMIC COST OF INACTION FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN GERMANY, JAPAN, AND THE UNITED STATES
    Younossi, Zobair
    Tacke, Frank
    Schattenberg, Joern
    Roden, Michael
    Lazarus, Jeffrey
    Allen, Alina
    Cusi, Kenneth
    Eguchi, Yuichiro
    Takahashi, Hirokazu
    Kawaguchi, Takumi
    Wong, Vincent
    Mark, Henry
    Brachowicz, Nicolai
    Henry, Linda
    Nader, Fatema
    Paik, James
    HEPATOLOGY, 2024, 80 : S816 - S817
  • [47] IMPACT OF FIBROSIS SEVERITY ON CLINICAL AND METAGENOMIC PROFILES IN MASH (METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS) PATIENTS
    Joung, Hyunchae
    Joo, Jaeryang
    Kim, KyungHwan
    Shin, Chang Hun
    Lee, Hye Won
    HEPATOLOGY, 2024, 80 : S788 - S789
  • [48] EXTRACELLULAR VESICLES AS A THERAPY FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) AND HEPATOCELLULAR CARCINOMA (HCC)
    Goonetilleke, M.
    Correia, J.
    Chen, Y.
    McDonald, H.
    Chan, S. T.
    Simpson, I.
    Inocencio, I. M.
    Sievert, W.
    Lim, R.
    CYTOTHERAPY, 2024, 26 (06) : S75 - S76
  • [49] Cost of inaction for metabolic dysfunction-associated steatohepatitis (MASH): the projected economic burden in the United States
    Younossi, Zobair
    Lazarus, Jeffrey V.
    Allen, Alina M.
    Cusi, Kenneth
    Tacke, Frank
    Roden, Michael
    Schattenberg, Jorn M.
    Mark, Henry E.
    Henry, Linda
    Nader, Fatema
    Paik, James M.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S470 - S471
  • [50] Metabolic Bariatric Surgery for the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH): A Scoping Review of Biomarker and Histology Changes
    Shah, A.
    Mohammadi, A.
    Haq, A.
    Walji, D.
    Zevin, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2025, 73 (01) : 297 - 299